Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. Here’s the funny thing about that ...

Two more voices have come out discussing Ben Johnson's pursuit of a head coaching ... investment companies as minority owners for teams. Mark Davis took advantage and sold some parts of the ...

Last month, former Bank of Canada governor Mark Carney appeared poised to become the country’s next finance minister. Now, he has an even bigger post in his sights. On Thursday, Carney announced he is ...

Diontae Johnson has been claimed on waivers by the Baltimore Ravens one day after he parted ways with the Houston Texans, according to ESPN's Adam Schefter. Johnson joined the Texans on Dec. 26 ...

Among those names are Tampa Bay Buccaneers offensive coordinator Liam Coen and Detroit Lions offensive coordinator Ben Johnson, two coaches who entered the process as potential favorites for ...

Oh, man, that’s way too fishy. With Brady’s status as a minority owner of a team seeking Johnson’s services, we have been presented with a massive conflict of interest involving the top head ...

Meta CEO Mark Zuckerberg reveals plans to replace midlevel software engineers with AI by 2025. The social media giant also intends to eliminate its DEI team and switch to community notes for fact ...

A top BlackRock executive, Mark Wiedman, who was considered a prospective successor to CEO Larry Fink, is leaving the world's largest asset manager, a person familiar with the matter said.

CEO Mark Zuckerberg said the decision to end fact-checking is an attempt to restore free expression on Meta’s platforms. Photo: Brendan Smialowski/Agence France-Presse/Getty Images Mark ...

Mark Zuckerberg wrapped up a very busy week of policy shifts — from scrapping DEI initiatives at Facebook to introducing recommendations for political content on Threads and Instagram — by ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...